Verus Capital Partners’s Humana HUM Stock Holding History

Verus Capital Partners’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-135	Closed	-$49K	–	1534
2019 Q4	$49K	Buy	+135	New	+$42.8K	0.02%	611

Other funds holding HUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Verus Capital Partners's HUM Position: Q1 2020 in Review

Verus Capital Partners sold out of Humana (HUM) in Q1 2020, closing a stake of 135 shares — an estimated $49K sold.

Verus Capital Partners first reported a position in HUM in Q4 2019 and held it in 1 quarter. The position peaked at $49K in Q4 2019. 782 funds tracked by Wall St. Rank hold HUM as of Q1 2020.

Verus Capital Partners reported no remaining Humana position as of Q1 2020 after selling out during the quarter.
Verus Capital Partners sold 135 Humana shares in Q1 2020, an estimated $49K.
Verus Capital Partners first reported a position in Humana in Q4 2019 and held it in 1 quarter.
Verus Capital Partners's Humana position peaked at $49K in Q4 2019.
782 funds tracked by Wall St. Rank held Humana as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.